RBC Capital Reiterates Outperform Rating on Regeneron Pharma (REGN)
Go back to RBC Capital Reiterates Outperform Rating on Regeneron Pharma (REGN)| Regeneron (NASDAQ: REGN) | Delayed: 667.95 +5.07 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $662.88 | 52 Week High | $592.36 | |||
| Open | $660.80 | 52 Week Low | $325.35 | |||
| Day High | $669.16 | P/E | 175.31 | |||
| Day Low | $660.80 | EPS | $3.81 | |||
| Volume | 672,528 | |||||

